CN110025583B - 一种具有优良稳定性的尼麦角林冻干制剂 - Google Patents
一种具有优良稳定性的尼麦角林冻干制剂 Download PDFInfo
- Publication number
- CN110025583B CN110025583B CN201910193830.3A CN201910193830A CN110025583B CN 110025583 B CN110025583 B CN 110025583B CN 201910193830 A CN201910193830 A CN 201910193830A CN 110025583 B CN110025583 B CN 110025583B
- Authority
- CN
- China
- Prior art keywords
- nicergoline
- hours
- injection
- sodium chloride
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910193830.3A CN110025583B (zh) | 2019-03-14 | 2019-03-14 | 一种具有优良稳定性的尼麦角林冻干制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910193830.3A CN110025583B (zh) | 2019-03-14 | 2019-03-14 | 一种具有优良稳定性的尼麦角林冻干制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110025583A CN110025583A (zh) | 2019-07-19 |
CN110025583B true CN110025583B (zh) | 2021-08-31 |
Family
ID=67236029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910193830.3A Active CN110025583B (zh) | 2019-03-14 | 2019-03-14 | 一种具有优良稳定性的尼麦角林冻干制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110025583B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114681410A (zh) * | 2021-10-27 | 2022-07-01 | 海南倍特药业有限公司 | 一种注射用尼麦角林的制备工艺 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1861076A (zh) * | 2005-05-13 | 2006-11-15 | 范敏华 | 一种尼麦角林冻干组合物及其制备方法 |
CN103054797A (zh) * | 2013-01-23 | 2013-04-24 | 海南锦瑞制药股份有限公司 | 一种泮托拉唑钠的药物组合物及其制备方法 |
CN103417474A (zh) * | 2012-05-15 | 2013-12-04 | 袁璐 | 含有二丁酰环磷腺苷钙的注射用组合物 |
CN105125505A (zh) * | 2015-08-10 | 2015-12-09 | 瑞阳制药有限公司 | 注射用盐酸托烷司琼冻干粉针及其制备方法 |
-
2019
- 2019-03-14 CN CN201910193830.3A patent/CN110025583B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1861076A (zh) * | 2005-05-13 | 2006-11-15 | 范敏华 | 一种尼麦角林冻干组合物及其制备方法 |
CN103417474A (zh) * | 2012-05-15 | 2013-12-04 | 袁璐 | 含有二丁酰环磷腺苷钙的注射用组合物 |
CN103054797A (zh) * | 2013-01-23 | 2013-04-24 | 海南锦瑞制药股份有限公司 | 一种泮托拉唑钠的药物组合物及其制备方法 |
CN105125505A (zh) * | 2015-08-10 | 2015-12-09 | 瑞阳制药有限公司 | 注射用盐酸托烷司琼冻干粉针及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110025583A (zh) | 2019-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5036060A (en) | Cyclophosphamide | |
CN102302463B (zh) | 注射用兰索拉唑冻干粉针剂及制备方法 | |
JP2019043969A (ja) | ある含有量のマイトマイシンcを有する凍結乾燥医薬組成物を製造する方法 | |
US10342769B2 (en) | Carmustine pharmaceutical composition | |
CN110025583B (zh) | 一种具有优良稳定性的尼麦角林冻干制剂 | |
KR101468153B1 (ko) | 5α-안드로스테인-3β,5,6β-트리올 주사제 및 제조방법 | |
CN102813632A (zh) | 一种稳定的胸腺法新制剂及其制备方法 | |
CN111904936B (zh) | 一种法莫替丁冻干粉针剂 | |
CN113679680A (zh) | 一种注射用兰索拉唑冻干粉及其制造方法 | |
WO2016045530A1 (zh) | 一种高复溶性及高稳定性的绿原酸冻干粉针 | |
CN103055305B (zh) | 一种注射用含细胞色素c药物组合物的冻干制剂、制备方法 | |
CN102657624B (zh) | 高光学纯度反式-右旋奥沙利铂冻干粉针剂及其制备方法 | |
EP2954894A1 (en) | Stable nocathiacin lyophilized powder injection agent | |
CN103585018A (zh) | 一种注射用还原型谷胱甘肽的新冻干方法 | |
CN108309944B (zh) | 注射用泮托拉唑钠及其制备方法 | |
CN103961322A (zh) | 一种注射用右旋兰索拉唑冻干组合物及其制备方法 | |
CN113797171B (zh) | 聚乙二醇化重组人粒细胞集落刺激因子冻干制剂 | |
CN104043103B (zh) | 一种多黏菌素e甲磺酸钠冻干制剂及其制备方法 | |
CN113967248A (zh) | 一种醋酸特利加压素冻干粉针剂及其制备方法 | |
CN113368063B (zh) | 一种注射用重组白细胞抑制因子和水蛭肽嵌合蛋白冻干制剂及其制备方法 | |
CN111514147B (zh) | 用于急性失代偿心力衰竭症状的左西孟旦钠药用组合物及制备方法 | |
CN103271884A (zh) | 一种兰索拉唑组合物及其制备方法 | |
CN104434821B (zh) | 一种注射用甲磺酸加贝酯组合物及其制备方法 | |
CN102743342A (zh) | 一种供注射用夫西地酸钠冻干组合物 | |
CN112353799A (zh) | 一种注射用西咪替丁组合物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230217 Address after: 437099 No. 6, Women Road, Economic Development Zone, Xian'an District, Xianning City, Hubei Province Patentee after: Hubei kelaiwei biopharmaceutical Co.,Ltd. Address before: 050035 rooms 201 and 202, unit 1, building 4, Fangyi Science Park, No. 313, Zhujiang Avenue, high tech Zone, Shijiazhuang, Hebei Patentee before: Hebei Jiamai Pharmaceutical Technology Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A freeze-dried preparation of Nimaijiaolin with excellent stability Effective date of registration: 20230508 Granted publication date: 20210831 Pledgee: Bank of China Limited Xianning branch Pledgor: Hubei kelaiwei biopharmaceutical Co.,Ltd. Registration number: Y2023420000190 |